The presence of cardiotropic viral genomes is not increased in atrial tissue of atrial fibrillation patients

[11] Chao TF(1986)Studies on the pathogenesis of atrial myocarditis in mice infected with Coxsackie virus B3 Br J Exp Pathol 67 43-563

[12] Liu CJ(2016)Viral myocarditis and dilated cardiomyopathy: etiology and pathogenesis Curr Pharm Des 22 408-1666

[13] Hsu JC(2011)Inflammatory pathways underlying atrial fibrillation Trends Mol Med 17 556-463

[14] Li Y(2009)Prevalence of parvovirus B19 and human bocavirus DNA in the heart of patients with no evidence of dilated cardiomyopathy or myocarditis Clin Infect Dis 49 1660-1441

[15] Marcus GM(2011)Virus reactivation: a panoramic view in human infections Future Virol 6 451-1791

[16] Cha M-J(2016)Relevance of cardiac parvovirus B19 in myocarditis and dilated cardiomyopathy: review of the literature Eur J Heart Fail 18 1430-110

[17] Seo H-M(2005)Differential aspects of endothelial function of the coronary microcirculation considering myocardial virus persistence, endothelial activation, and myocardial leukocyte infiltrates Circulation 111 1784-1227

[18] Choi E-K(2009)High prevalence of human parvovirus B19 DNA in myocardial autopsy samples from subjects without myocarditis or dilative cardiomyopathy J Clin Microbiol 47 106-360

[19] Chiang CH(2000)Enteroviruses can persist with or without active viral replication in cardiac tissue of patients with end-stage ischemic or dilated cardiomyopathy J Infect Dis 182 1222-undefined

[20] Huang CC(2000)Cardiac surgery in patients infected with human immunodeficiency virus Tex Heart Inst J 27 356-undefined

[11] Chao TF(1986)Studies on the pathogenesis of atrial myocarditis in mice infected with Coxsackie virus B3 Br J Exp Pathol 67 43-563

[12] Liu CJ(2016)Viral myocarditis and dilated cardiomyopathy: etiology and pathogenesis Curr Pharm Des 22 408-1666

[13] Hsu JC(2011)Inflammatory pathways underlying atrial fibrillation Trends Mol Med 17 556-463

[14] Li Y(2009)Prevalence of parvovirus B19 and human bocavirus DNA in the heart of patients with no evidence of dilated cardiomyopathy or myocarditis Clin Infect Dis 49 1660-1441

[15] Marcus GM(2011)Virus reactivation: a panoramic view in human infections Future Virol 6 451-1791

[16] Cha M-J(2016)Relevance of cardiac parvovirus B19 in myocarditis and dilated cardiomyopathy: review of the literature Eur J Heart Fail 18 1430-110

[17] Seo H-M(2005)Differential aspects of endothelial function of the coronary microcirculation considering myocardial virus persistence, endothelial activation, and myocardial leukocyte infiltrates Circulation 111 1784-1227

[18] Choi E-K(2009)High prevalence of human parvovirus B19 DNA in myocardial autopsy samples from subjects without myocarditis or dilative cardiomyopathy J Clin Microbiol 47 106-360

[19] Chiang CH(2000)Enteroviruses can persist with or without active viral replication in cardiac tissue of patients with end-stage ischemic or dilated cardiomyopathy J Infect Dis 182 1222-undefined

[20] Huang CC(2000)Cardiac surgery in patients infected with human immunodeficiency virus Tex Heart Inst J 27 356-undefined